Comparison of pharmacoeconomic (PE) evaluations for drugs for rare diseases (DRDs) evaluated by CADTH and NICE

Gosain, S., Bullement, A. orcid.org/0000-0001-7091-0972, Kirby, J. et al. (3 more authors) (2018) Comparison of pharmacoeconomic (PE) evaluations for drugs for rare diseases (DRDs) evaluated by CADTH and NICE. In: Value in Health. ISPOR Europe 2018: New Perspectives for Improving 21st Century Health Systems, 10-14 Nov 2018, Barcelona, Spain. Elsevier , S465.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Published by Elsevier Inc. This is an author produced version of an abstract subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Published (online): 24 December 2018
  • Published: 24 December 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 22 Jan 2021 11:21
Last Modified: 22 Jan 2021 11:21
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.jval.2018.09.2741
Related URLs:

Share / Export

Statistics